Boothbay Fund Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-20,054
| Closed | -$37K | – | 1992 |
|
|
2022
Q2 | $37K | Buy |
20,054
+6,953
| +53% | +$12.8K | ﹤0.01% | 1842 |
|
|
2022
Q1 | $35K | Buy |
+13,101
| New | +$35K | ﹤0.01% | 1827 |
|
|
2021
Q3 | – | Sell |
-15,182
| Closed | -$96K | – | 1701 |
|
|
2021
Q2 | $96K | Sell |
15,182
-80,102
| -84% | -$507K | ﹤0.01% | 1575 |
|
|
2021
Q1 | $737K | Buy |
+95,284
| New | +$737K | 0.03% | 598 |
|
|
2020
Q3 | – | Sell |
-14,595
| Closed | -$122K | – | 951 |
|
|
2020
Q2 | $122K | Buy |
14,595
+695
| +5% | +$5.81K | 0.01% | 733 |
|
|
2020
Q1 | $107K | Buy |
+13,900
| New | +$107K | 0.01% | 624 |
|
|
2019
Q1 | – | Sell |
-10,000
| Closed | -$151K | – | 674 |
|
|
2018
Q4 | $151K | Buy |
+10,000
| New | +$151K | 0.02% | 436 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 685 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 644 |
|